Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
47 Results Found
Supporting Hospital and Health System Boards as We Navigate a Changing Health Care Landscape
The many complexities of health care today continue to challenge hospital and health system governing boards to ensure that high-quality patient care is provided to the communities they serve.
Health Care Risk Management (HRM) Core Program
HRM Core is immediate, on-demand orientation training that risk professionals can complete while waiting for more comprehensive in-person professional development with ASHRM’s HRM Certification Program.
White Paper: Recognizing and Managing Bias
This white paper series promotes awareness, addresses the need for authentic conversations
and insights, and ideally encourages sustainable changes regarding implicit bias within health care
organizations.
Enterprise Risk Management for Health Care, Fourth Edition
The Enterprise Risk Management for Health Care, Fourth Edition, from AHLA and ASHRM addresses both the need for, and implementation of, a comprehensive enterprise risk management process and plan.
Relief fund created to benefit hospital workers displaced by tornado outbreak in Nebraska
The Nebraska Hospital Association has established a relief fund following a tornado outbreak April 26.
Boardroom Brief: Encouraging a Risk-aware Culture to Drive Value
A new Boardroom Brief from AHA Trustee Services and the American Society for Health Care Risk Management offers guidance and resources to help boards drive value through enterprise risk management.
COVID-19 Vaccine #MyWhy: Faye Sheppard
Learn about #MyWhy Campaign and what health care risk professionals are doing to increase vaccination rates in their communities.
CMS updates informed consent guidance for hospitals
The Centers for Medicare & Medicaid Services April 1 revised its Hospital Interpretative Guidelines for Informed Consent to clarify the need to obtain informed consent from patients before medical students or other students perform important surgical tasks or sensitive or invasive procedures or examinations.
FDA withdraws accelerated approval of myeloma drug
The Food and Drug Administration Feb. 23 withdrew approval of Pepaxto (melphalan flufenamide), a drug once used with dexamethasone to treat certain U.S. patients with multiple myeloma, because a post-approval trial did not show it safe or effective.